Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Infliximab in Pediatric Inflammatory Bowel Disease: A Systematic Review and Revised Dosing Considerations

DA Winter; Linda Joosse; Saskia de Wildt; J Taminiau; Lissy de Ridder; Hankje Escher

doi:10.1097/mpg.0000000000002631

Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Infliximab in Pediatric Inflammatory Bowel Disease: A Systematic Review and Revised Dosing Considerations

DA Winter, Linda Joosse, Saskia de Wildt, J Taminiau, Lissy de Ridder, Hankje Escher

Research output: Contribution to journal › Article › Academic › peer-review

32 Citations (Scopus)

Original language	English
Pages (from-to)	763-776
Number of pages	14
Journal	Journal of Pediatric Gastroenterology and Nutrition
Volume	70
Issue number	6
DOIs	https://doi.org/10.1097/mpg.0000000000002631
Publication status	Published - 2020

Research programs

EMC MM-04-54-07

Access to Document

10.1097/mpg.0000000000002631

http://hdl.handle.net/1765/130616

Cite this

@article{cf7a88b1cf8a43839a92c0ae2d4cf4b9,

title = "Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Infliximab in Pediatric Inflammatory Bowel Disease: A Systematic Review and Revised Dosing Considerations",

author = "DA Winter and Linda Joosse and {de Wildt}, Saskia and J Taminiau and {de Ridder}, Lissy and Hankje Escher",

year = "2020",

doi = "10.1097/mpg.0000000000002631",

language = "English",

volume = "70",

pages = "763--776",

journal = "Journal of Pediatric Gastroenterology and Nutrition",

issn = "0277-2116",

publisher = "John Wiley & Sons Inc.",

number = "6",

}

Winter, DA, Joosse, L , de Wildt, S, Taminiau, J, de Ridder, L & Escher, H 2020, 'Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Infliximab in Pediatric Inflammatory Bowel Disease: A Systematic Review and Revised Dosing Considerations', Journal of Pediatric Gastroenterology and Nutrition, vol. 70, no. 6, pp. 763-776. https://doi.org/10.1097/mpg.0000000000002631

Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Infliximab in Pediatric Inflammatory Bowel Disease: A Systematic Review and Revised Dosing Considerations. / Winter, DA; Joosse, Linda ; de Wildt, Saskia et al.
In: Journal of Pediatric Gastroenterology and Nutrition, Vol. 70, No. 6, 2020, p. 763-776.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Infliximab in Pediatric Inflammatory Bowel Disease: A Systematic Review and Revised Dosing Considerations

AU - Winter, DA

AU - Joosse, Linda

AU - de Wildt, Saskia

AU - Taminiau, J

AU - de Ridder, Lissy

AU - Escher, Hankje

PY - 2020

Y1 - 2020

U2 - 10.1097/mpg.0000000000002631

DO - 10.1097/mpg.0000000000002631

M3 - Article

SN - 0277-2116

VL - 70

SP - 763

EP - 776

JO - Journal of Pediatric Gastroenterology and Nutrition

JF - Journal of Pediatric Gastroenterology and Nutrition

IS - 6

ER -